Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| DGX | QUEST DIAGNOSTICS INC | 2025-10-16 19:43:52 | 186.08 | -0.74 | -0.4 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DGX | 0001022079 | QUEST DIAGNOSTICS INC | US74834L1008 | 8MCWUBXQ0WE04KMXBX50 | 161387862 | NYSE | 8071 | Services-Medical Laboratories | 1231 | DE | 500 PLAZA DRIVE | SECAUCUS | NJ | 07094 | UNITED STATES | US | 9735202700 | 500 PLAZA DRIVE, SECAUCUS, NJ, 07094 | 500 PLAZA DRIVE, SECAUCUS, NJ, 07094 | CORNING CLINICAL LABORATORIES INC | Health care | 1967 | Jim Davis | 56,000 | https://questdiagnostics.com | 15,200,000,000 | 162,000,000 | 111,823,441 | Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. | 2025-10-10 19:30:36 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 15,200,000,000 | -500,000,000 | -3.1847 | 110,978,069 | 270,776 | 0.2446 |
| 2023 | 15,700,000,000 | 300,000,000 | 1.9481 | 110,707,293 | -615,710 | -0.5531 |
| 2022 | 15,400,000,000 | -700,000,000 | -4.3478 | 111,323,003 | -8,131,778 | -6.8074 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Catherine T. Doherty | Executive Vice President | 2024 | 618,269 | 0 | 1,593,772 | 477,798 | 46,420 | 3,286,080 |
| Michael E. Prevoznik | General Counsel, Senior Vice President | 2024 | 550,000 | 0 | 1,086,688 | 371,910 | 45,174 | 2,428,646 |
| James E. Davis | President, Chairman, Chief Executive Officer | 2024 | 1,250,000 | 0 | 8,239,724 | 1,811,250 | 260,258 | 14,404,862 |
| Sam A. Samad | Chief Financial Officer, Executive Vice President | 2024 | 668,269 | 0 | 2,028,350 | 580,993 | 90,971 | 4,068,464 |
| Karthik Kuppusamy | Senior Vice President | 2024 | 543,269 | 0 | 978,040 | 367,359 | 51,664 | 2,277,691 |
| Fiscal Year | Employee Count |
|---|---|
| 2024 | 56,000 |
| 2023 | 48,000 |
| 2022 | 49,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 9,872,000,000 | 9,252,000,000 | 9,883,000,000 |
| Cost Of Revenue | 6,628,000,000 | 6,199,000,000 | 6,450,000,000 |
| Gross Profit | — | — | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 1,770,000,000 | 1,642,000,000 | 1,874,000,000 |
| Operating Expenses | 8,526,000,000 | 7,990,000,000 | 8,455,000,000 |
| Operating Income | 1,346,000,000 | 1,262,000,000 | 1,428,000,000 |
| Net Income | 871,000,000 | 854,000,000 | 946,000,000 |
| Earnings Per Share Basic | 7.78 | 7.59 | 8.1 |
| Earnings Per Share Diluted | 7.69 | 7.49 | 7.97 |
| Weighted Average Shares Outstanding Basic | 111,000,000 | 112,000,000 | 116,000,000 |
| Weighted Average Shares Outstanding Diluted | 113,000,000 | 113,000,000 | 118,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 549,000,000 | 686,000,000 | 315,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 1,304,000,000 | 1,210,000,000 | 1,195,000,000 |
| Inventories | 188,000,000 | 190,000,000 | 192,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 40,000,000 | 36,000,000 | 35,000,000 |
| Total Assets Current | 2,392,000,000 | 2,372,000,000 | 1,898,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 2,113,000,000 | 1,816,000,000 | 1,766,000,000 |
| Other Assets Non Current | 255,000,000 | 198,000,000 | 144,000,000 |
| Total Assets Non Current | 13,761,000,000 | 11,650,000,000 | 10,939,000,000 |
| Total Assets | 16,153,000,000 | 14,022,000,000 | 12,837,000,000 |
| Accounts Payable | 287,000,000 | 378,000,000 | 324,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 602,000,000 | 303,000,000 | 2,000,000 |
| Other Liabilities Current | 306,000,000 | 287,000,000 | 392,000,000 |
| Total Liabilities Current | 2,169,000,000 | 1,815,000,000 | 1,551,000,000 |
| Long Term Debt | 6,217,000,000 | 4,713,000,000 | 3,980,000,000 |
| Other Liabilities Non Current | 938,000,000 | 876,000,000 | 812,000,000 |
| Total Liabilities Non Current | — | — | — |
| Total Liabilities | — | — | — |
| Common Stock | 2,000,000 | 2,000,000 | 2,000,000 |
| Retained Earnings | 9,360,000,000 | 8,825,000,000 | 8,290,000,000 |
| Accumulated Other Comprehensive Income | -88,000,000 | -14,000,000 | -21,000,000 |
| Total Shareholders Equity | 6,778,000,000 | 6,307,000,000 | 5,893,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 493,000,000 | 439,000,000 | 437,000,000 |
| Share Based Compensation Expense | 88,000,000 | 77,000,000 | 77,000,000 |
| Other Non Cash Income Expense | -15,000,000 | -41,000,000 | -66,000,000 |
| Change In Accounts Receivable | 71,000,000 | 15,000,000 | -246,000,000 |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | -67,000,000 | -55,000,000 | -149,000,000 |
| Change In Other Liabilities | 79,000,000 | 73,000,000 | -53,000,000 |
| Cash From Operating Activities | 1,334,000,000 | 1,272,000,000 | 1,718,000,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | — |
| Acquisition Of Property Plant And Equipment | 425,000,000 | 408,000,000 | 404,000,000 |
| Acquisition Of Business | 2,164,000,000 | 611,000,000 | 144,000,000 |
| Other Investing Activities | -41,000,000 | 42,000,000 | -5,000,000 |
| Cash From Investing Activities | -2,548,000,000 | -1,061,000,000 | -543,000,000 |
| Tax Withholding For Share Based Compensation | 24,000,000 | 28,000,000 | 28,000,000 |
| Payments Of Dividends | 336,000,000 | 319,000,000 | 305,000,000 |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 151,000,000 | 275,000,000 | 1,408,000,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 21,000,000 | 14,000,000 | -39,000,000 |
| Cash From Financing Activities | 1,084,000,000 | 160,000,000 | -1,732,000,000 |
| Change In Cash | -137,000,000 | 371,000,000 | -557,000,000 |
| Cash At End Of Period | 549,000,000 | 686,000,000 | 315,000,000 |
| Income Taxes Paid | 256,000,000 | 317,000,000 | 283,000,000 |
| Interest Paid | 262,000,000 | 134,000,000 | 156,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 7.78 | 7.59 | 8.1 |
| Price To Earnings Ratio | 19.3907 | 18.166 | 19.3136 |
| Earnings Growth Rate | 2.5033 | -6.2963 | -48.8959 |
| Price Earnings To Growth Ratio | 7.7461 | -2.8852 | -0.395 |
| Book Value Per Share | 125.982 | 108.9911 | 97.2931 |
| Price To Book Ratio | 1.1975 | 1.2651 | 1.6079 |
| Ebitda | 1,419,000,000 | 1,773,000,000 | 1,814,000,000 |
| Enterprise Value | 23,015,460,000 | 19,772,560,000 | 21,814,040,000 |
| Dividend Yield | 0.0201 | 0.0207 | 0.0168 |
| Dividend Payout Ratio | 0.3858 | 0.3735 | 0.3224 |
| Debt To Equity Ratio | 1.006 | 0.7953 | 0.6757 |
| Capital Expenditures | 790,000,000 | 489,000,000 | 496,000,000 |
| Free Cash Flow | 544,000,000 | 783,000,000 | 1,222,000,000 |
| Return On Equity | 0.1285 | 0.1354 | 0.1605 |
| One Year Beta | 0.2492 | 0.3796 | 0.5503 |
| Three Year Beta | 0.4613 | 0.446 | 0.6397 |
| Five Year Beta | 0.5898 | 0.6223 | 0.6512 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Lassiter Wright III | Director | 2025-10-01 | 157 | A | 678 |
| RING TIMOTHY M | Director | 2025-10-01 | 233 | A | 17,036 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2025-09-26 | 227 | A | 38,344 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2025-09-26 | 83 | D | 38,261 |
| PREVOZNIK MICHAEL E | SVP & General Counsel | 2025-09-26 | 144 | D | 38,117 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2024-02-14 | Sale (Partial) | 2024-01-03 | Joint | $15,001 - $50,000 |
| Thomas R Carper | Senator | 2024-01-03 | Sale (Partial) | 2023-12-11 | Spouse | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2021-07-23 | Purchase | 2021-03-29 | Joint | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2021-05-17 | Purchase | 2020-04-02 | Spouse | $1,001 - $15,000 |
| Thomas R Carper | Senator | 2020-05-04 | Purchase | 2020-04-02 | Spouse | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Carol Devine Miller | 2025-04-11 | WV01 | Sale | 2025-03-10 | — | $1,001 - $15,000 |
| Earl Blumenauer | 2024-05-04 | OR03 | Sale | 2024-04-04 | Spouse | $1,001 - $15,000 |
| Carol Devine Miller | 2022-12-13 | WV03 | Purchase | 2022-11-14 | — | $1,001 - $15,000 |
| Kathy Manning | 2022-09-14 | NC06 | Sale | 2022-08-03 | Joint | $1,001 - $15,000 |
| Carol Devine Miller | 2022-09-02 | WV03 | Purchase | 2021-07-28 | Spouse | $15,001 - $50,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TOWNSEND ASSET MANAGEMENT CORP /NC/ /ADV | 2025-09-30 | 228,315 | 1,198 | 190.5801 |
| Capital Advisors, Ltd. LLC | 2025-09-30 | 240,000 | 1,257 | 190.9308 |
| WEATHERLY ASSET MANAGEMENT L. P. | 2025-09-30 | 2,410,266 | 12,647 | 190.5801 |
| BURNEY CO/ | 2025-09-30 | 737,378 | 3,869 | 190.5862 |
| HBK Sorce Advisory LLC | 2025-09-30 | 389,126 | 2,077 | 187.35 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Fund | CFMCX | 13,434 | 2,440,151.76 | 0.2448 |
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Select Fund | CFMSX | 29,674 | 5,389,985.36 | 0.2077 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 6,930 | 1,160,151.3 | 0.0348 |
| Pacer Funds Trust | 2025-07-31 | Pacer MSCI World Industry Advantage ETF | GLBL | 3 | 502.23 | 0.0542 |
| Pacer Funds Trust | 2025-07-31 | Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | QDPL | 2,030 | 339,842.3 | 0.0312 |